Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT01865474
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 122 participants
- Sponsor
- Registry
-
NCT01865474
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Indonesia
- Registry status
- Completed
Technical summary
Registry record NCT01865474. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2016-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- DLBS1033
- Intervention (Drug)
- placebo tablet of DLBS1033
- Lead sponsor
- Dexa Medica Group
Record details
- Record id
cardio:ct-nct01865474- Content hash
d1df4d43ecffa120189fa1b4d7f3fcd995a31c71dfc7cd4cbe409d2a1c17560f